University of Iowa Lab to Launch Sequencing-based Genetic Deafness Test this Summer
March 22, 2011
University of Iowa Lab to Launch Sequencing-based Genetic Deafness Test this Summer
The test uses Agilent's SureSelect in-solution capture and Illumina's sequencing platform to screen nearly 60 known non-syndromic hearing loss genes for pathogenic mutations, which are confirmed by Sanger sequencing.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Partners Healthcare to Move Cardiomyopathy Genetic Test from Microarray to Illumina HiSeq
May 11, 2011 / Clinical Sequencing News - Illumina to Apply Rare-Cell Capture to Ovarian Cancer Program; Expects Clinical Apps for MiSeq
May 4, 2011 / Clinical Sequencing News - At AGBT, Illumina Highlights Moleculo, New Applications for HiSeq and MiSeq, Planned Improvements
February 26, 2013 / In Sequence - Illumina Plans MiSeq Disease Panels, CLIA RapidTrack Whole-Genome Sequencing Service
July 25, 2012 / Clinical Sequencing News - Canadian Clinical Dx Genomics Center to Start Cancer Predisposition Testing on HiSeq
February 1, 2012 / Clinical Sequencing News